CDER Will Add 115 Review Positions In Fiscal 1999 From PDUFA II Funds
Executive Summary
FDA's Center for Drug Evaluation & Research drug review process will get an additional 240 full time positions by 2002 from funds made available by prescription drug user fees.
You may also be interested in...
User Fee Revision Reduces Expected CDER Staffing Increases By 139 FTEs
A revision of FDA's estimated revenues from user fees will reduce the expected additions in staff to the Center for Drug Evaluation & Research to 40% of previous estimates.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011